Abstract
As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Current Bioinformatics
Title: Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †
Volume: 7 Issue: 1
Author(s): Qiuli Liu, Xianping Guo and Tianshou Zhou
Affiliation:
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Abstract: As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Export Options
About this article
Cite this article as:
Liu Qiuli, Guo Xianping and Zhou Tianshou, Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †, Current Bioinformatics 2012; 7 (1) . https://dx.doi.org/10.2174/157489312799304486
DOI https://dx.doi.org/10.2174/157489312799304486 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in the Design and Synthesis of Prednisolone and Methylprednisolone Conjugates
Current Pharmaceutical Design Solid-Phase Synthesis of Oligosaccharide Drugs: A Review
Mini-Reviews in Medicinal Chemistry Determination of the Sodium Concentration in Brazilian Light and Non- Light Powdered Instant Soups by Flame Photometry
Current Nutrition & Food Science Exploring the Binding Affinity of Novel Syringic Acid Analogues and Critical Determinants of Selectivity as Potent Proteasome Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Antifungal Activity and Carbonic Anhydrase Inhibitory Properties of Cu (II) Bis (3, 4 Dimethoxybenzoate) Bis (Nicotinamide) Dihydrate
Current Enzyme Inhibition Proteome Analysis Revealed Jak/Stat Signaling and Cytoskeleton Rearrangement Proteins in Human Lung Epithelial Cells During Interaction with Aspergillus terreus
Current Signal Transduction Therapy From Nanotechnology to Nanomedicine: Applications to Cancer Research
Current Molecular Medicine Curcumin-based Nanoformulations to Target Breast Cancer: Current Trends and Challenges
Current Nanomaterials Review: Metabolism of Immunosuppressant Drugs
Current Drug Metabolism Application of Immunological Techniques (from Vaccination to Final Measurements) in Determination of Pharmaceutical Residues in Environmental Samples
Current Analytical Chemistry The Fabrication and Application of Bio-Functional Microspheres
Current Organic Chemistry Combinatorial Dansyl Library and its Applications to pH-Responsive Probes
Combinatorial Chemistry & High Throughput Screening DNA Double Strand Breaks: A Common Theme in Neurodegenerative Diseases
Current Alzheimer Research Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
Current Protein & Peptide Science Crystal Structure of a Flavin-dependent Thymidylate Synthase from Helicobacter pylori strain 26695
Protein & Peptide Letters Design, Synthesis and Biological Evaluation of 4-(Imidazolylmethyl)-2- Aryl-Quinoline Derivatives as Aromatase Inhibitors and Anti-breast Cancer Agents
Letters in Drug Design & Discovery Synergism of Temozolomide, Metformin, and Epigallocatechin Gallate Promotes Oxidative Stress-Induced Apoptosis in Glioma Cells
Current Drug Therapy Structure-Activity Relationships of Flavonoids
Current Organic Chemistry Phycobiliproteins: A Novel Green Tool from Marine Origin Blue-Green Algae and Red Algae
Protein & Peptide Letters Cyclopeptides from Marine Organisms
Mini-Reviews in Organic Chemistry